Daxor Corporation DXR
11.01
(0.38)
(3.34%)
as of 25 Sep
- Market cap
- $66.5M
- P/E
- 5.1×
Follow DXR
Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '21 | Jun '22 | Dec '22 | Jun '23 | |
|---|---|---|---|---|---|
|
+7 more TTM periods Free account |
17.94% | 31.06% | 44.47% | 37.62% | |
| 15.53% | 25.53% | 42.41% | 35.90% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.40) | (1.49) | (1.55) | (1.68) | |
Free Cash Flow |
(5.65) | (6.02) | (6.29) | (7.52) | |
Piotroski F-Score |
2.00 | 3.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(22.70%) | (26.86%) | (20.84%) | (24.77%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
(1.86) | (1.26) | (0.63) | (0.89) | |
Revenue per Share |
(1.34) | (1.02) | (0.73) | (0.75) | |
Operating CF per Share |
(1.40) | (1.49) | (1.55) | (1.68) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(56.12%) | (115.70%) | (334.39%) | (251.91%) |
Columns are period end dates